Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10232)
All Articles published online
|
Publishing Process of This Article
|
Sep 26, 2019 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ke M, Chong CM, Su H. Using induced pluripotent stem cells for modeling Parkinson’s disease. World J Stem Cells 2019; 11(9): 634-649 [PMID: 31616540 DOI: 10.4252/wjsc.v11.i9.634] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v11/i9/634.htm |
| Number | Citing Articles |
| 1 |
Tuuli-Maria Sonninen, Lidiia Plotnikova, Nihay Laham-Karam, Gundars Goldsteins, Jari Koistinaho, Šárka Lehtonen. iPSCs for Modeling Central Nervous System Disorders. 2021; : 251 doi: 10.1016/B978-0-323-85764-2.00009-0
|
| 2 |
Minyoung Oh, Juhyeon Nam, Areum Baek, Ji-Hye Seo, Jung-Il Chae, Seo-Young Lee, Sun-Ku Chung, Byoung Chul Park, Sung Goo Park, Janghwan Kim, Young-Joo Jeon. Neuroprotective Effects of Licochalcone D in Oxidative-Stress-Induced Primitive Neural Stem Cells from Parkinson’s Disease Patient-Derived iPSCs. Biomedicines 2023; 11(1): 228 doi: 10.3390/biomedicines11010228
|
| 3 |
Niloufar Yousefi, Shahla Abdollahii, Mohammad Amin Jadidi Kouhbanani, Ali Hassanzadeh. Induced pluripotent stem cells (iPSCs) as game‐changing tools in the treatment of neurodegenerative disease: Mirage or reality?. Journal of Cellular Physiology 2020; 235(12): 9166 doi: 10.1002/jcp.29800
|
| 4 |
Ying Zhang, Xinyang Xie, Jiangnan Hu, Kazi Sabrina Afreen, Chun-Li Zhang, Qichuan Zhuge, Jianjing Yang. Prospects of Directly Reprogrammed Adult Human Neurons for Neurodegenerative Disease Modeling and Drug Discovery: iN vs. iPSCs Models. Frontiers in Neuroscience 2020; 14 doi: 10.3389/fnins.2020.546484
|
| 5 |
Jiabin Liu, Jieqiong Tan, Beisha Tang, Jifeng Guo. Unveiling the role of iPLA2β in neurodegeneration: From molecular mechanisms to advanced therapies. Pharmacological Research 2024; 202: 107114 doi: 10.1016/j.phrs.2024.107114
|
| 6 |
Jiajia Xu, Yangyang Li, Huan Zhu, Wenyu Wu, Yumeng Liu, Yu Guo, Weijun Guan, Changqing Liu, Caiyun Ma. Therapeutic function of a novel rat induced pluripotent stem cell line in a 6‑OHDA‑induced rat model of Parkinson's disease. International Journal of Molecular Medicine 2022; 50(6) doi: 10.3892/ijmm.2022.5196
|
| 7 |
Bhavana Muralidharan. Translational Biotechnology. 2021; : 81 doi: 10.1016/B978-0-12-821972-0.00013-7
|
| 8 |
Ainsley Mike Antao, Janardhan Keshav Karapurkar, Dong Ryul Lee, Kye-Seong Kim, Suresh Ramakrishna. Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems. Computational and Structural Biotechnology Journal 2020; 18: 3649 doi: 10.1016/j.csbj.2020.11.026
|
| 9 |
David Arango, Amaury Bittar, Natalia P. Esmeral, Camila Ocasión, Carolina Muñoz-Camargo, Juan C. Cruz, Luis H. Reyes, Natasha I. Bloch. Understanding the Potential of Genome Editing in Parkinson’s Disease. International Journal of Molecular Sciences 2021; 22(17): 9241 doi: 10.3390/ijms22179241
|
| 10 |
Kaavya Jayaramayya, Mahalaxmi Iyer, Dhivya Venkatesan, Venkatesh Balasubramanian, Arul Narayanasamy, Mohana Devi Subramaniam, Ssang Goo Cho, Balachandar Vellingiri. Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson’s disease (PD) – A road to discovery?. Brain Research Bulletin 2020; 157: 169 doi: 10.1016/j.brainresbull.2020.02.001
|
| 11 |
Tirthankar Sen, Rajkumar P. Thummer. CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics. Neurotoxicity Research 2022; 40(5): 1597 doi: 10.1007/s12640-022-00564-w
|
| 12 |
Yu Guo, Yuan-Yuan Wang, Ting-Ting Sun, Jia-Jia Xu, Pan Yang, Cai-Yun Ma, Wei-Jun Guan, Chun-Jing Wang, Gao-Feng Liu, Chang-Qing Liu. Neural progenitor cells derived from fibroblasts induced by small molecule compounds under hypoxia for treatment of Parkinson’s disease in rats. Neural Regeneration Research 2023; 18(5): 1090 doi: 10.4103/1673-5374.355820
|
| 13 |
S. A. Antonov, E. V. Novosadova. Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson’s Disease Drug Development. International Journal of Molecular Sciences 2021; 22(7): 3381 doi: 10.3390/ijms22073381
|
| 14 |
Joo-Eun Lee, Hyuna Sim, Hee Min Yoo, Minhyung Lee, Aruem Baek, Young-Joo Jeon, Kang-Sik Seo, Mi-Young Son, Joo Seog Yoon, Janghwan Kim. Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease. Molecules 2020; 25(16): 3602 doi: 10.3390/molecules25163602
|
| 15 |
Pia Rivetti di Val Cervo, Dario Besusso, Paola Conforti, Elena Cattaneo. hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible. Nature Reviews Neurology 2021; 17(6): 381 doi: 10.1038/s41582-021-00465-0
|
| 16 |
A. Katherine Hatstat, Michael D. Pupi, Michaela C. Reinhart, Dewey G. McCafferty. Small Molecule Improvement of Trafficking Defects in Models of Neurodegeneration. ACS Chemical Neuroscience 2021; 12(21): 3972 doi: 10.1021/acschemneuro.1c00524
|
| 17 |
Babak Arjmand, Shayesteh Kokabi-Hamidpour, Hamid Reza Aghayan, Sepideh Alavi-Moghadam, Rasta Arjmand, Mostafa Rezaei-Tavirani, Parisa Goodarzi, Ensieh Nasli-Esfahani, Mohsen Nikandish. . Methods in Molecular Biology 2023; doi: 10.1007/7651_2022_473
|
| 18 |
Elena Coccia, Tim Ahfeldt. Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02326-5
|
| 19 |
Yiran Xu, Shuxia Wang, Ping Zhu. Advances in the Application of Induced Pluripotent Stem Cells in Alzheimer’s Disease and Parkinson's Disease. Current Stem Cell Research & Therapy 2023; 18(2): 154 doi: 10.2174/1574888X17666220426114050
|
| 20 |
Julian Krauskopf, Kristel Eggermont, Rodrigo Furtado Madeiro Da Costa, Sacha Bohler, Duncan Hauser, Florian Caiment, Theo M. de Kok, Catherine Verfaillie, Jos C. Kleinjans. Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson’s disease. Molecular Psychiatry 2022; 27(10): 4355 doi: 10.1038/s41380-022-01663-y
|
| 21 |
V. Valadez-Barba, K. Juárez-Navarro, E. Padilla-Camberos, N.F. Díaz, J.R. Guerra-Mora, N.E. Díaz-Martínez. Parkinson’s disease: an update on preclinical studies of induced pluripotent stem cells. Neurología (English Edition) 2023; 38(9): 681 doi: 10.1016/j.nrleng.2023.10.004
|
| 22 |
Shiyao Hua, Jiayue Liu, Liang Zou, Peng Li. Handbook of Dietary Flavonoids. 2023; : 1 doi: 10.1007/978-3-030-94753-8_27-1
|
| 23 |
V. Valadez-Barba, K. Juárez-Navarro, E. Padilla-Camberos, N.F. Díaz, J.R. Guerra-Mora, N.E. Díaz-Martínez. Enfermedad de Parkinson: actualización de estudios preclínicos con el uso de células troncales pluripotentes inducidas. Neurología 2023; 38(9): 681 doi: 10.1016/j.nrl.2021.01.005
|